Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
PM-8002 by Biotheus for Small-Cell Lung Cancer: Likelihood of Approval
PM-8002 is under clinical development by Biotheus and currently in Phase II for Small-Cell Lung Cancer. According to GlobalData, Phase...
PM-8002 by Biotheus for Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast Cancer): Likelihood of Approval
PM-8002 is under clinical development by Biotheus and currently in Phase II for Human Epidermal Growth Factor Receptor 2 Positive...
PM-8002 by Biotheus for Triple-Negative Breast Cancer (TNBC): Likelihood of Approval
PM-8002 is under clinical development by Biotheus and currently in Phase II for Triple-Negative Breast Cancer (TNBC). According to GlobalData,...